Metabolic tumor volume on FDG-PET/CT is a possible prognostic factor for Stage i lung cancer patients treated with stereotactic body radiation therapy: A retrospective clinical study
Dive into the research topics of 'Metabolic tumor volume on FDG-PET/CT is a possible prognostic factor for Stage i lung cancer patients treated with stereotactic body radiation therapy: A retrospective clinical study'. Together they form a unique fingerprint.